clinical trials for glp 1 Continued growth GLP-1 receptor agonists and SGLT-2 inhibitors in 2017 GLP-1 Drugs: The Science and

A separate survey released in May by the Business Group on Health, a Washington, D.C.-based nonprofit focused on employer healthcare policy, found that 67% of employers cover GLP-1 drugs for weight management, though many impose conditions aimed at limiting their use or ensuring clinical oversight

They also protect the heart and kidneys in people with higher risks

PlexusDx's Precision Peptide Genetic Test maps fourteen metabolic pathways and identifies genetic insights that predict your response profile, helping clinicians anticipate whether a lower or higher maintenance dose will work best for you

Beyond weight management, semaglutide shows promise in addressing cardiovascular risks and improving blood sugar control in patients with diabetes